Scientists launch global effort to decode rare genetic disorder
NCT ID NCT07699510
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study is an international registry that collects medical, genetic, and developmental information from people with changes in the TNPO2 gene. Researchers aim to better understand how these gene variants affect health and development over time. By analyzing blood samples, they hope to uncover the biological mechanisms behind the disorder. The study does not test any treatment but lays the groundwork for future therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward future treatments for TNPO2-associated disorders by clarifying how the gene variant causes disease.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test any therapy, and findings may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNPO2 are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité- Universitätsmedizin Berlin
RECRUITINGBerlin, State of Berlin, 13353, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.